We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+46.38%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$177M
AUM Growth
-$23.1M
Cap. Flow
-$42.9M
Cap. Flow %
-24.17%
Top 10 Hldgs %
54.35%
Holding
88
New
28
Increased
3
Reduced
8
Closed
48

Top Buys

Rank Stock Value
1
MDLN
Medline Inc
MDLN
+$12.7M
2
SOFI icon
SoFi Technologies
SOFI
+$11.1M
3
ULS icon
UL Solutions
ULS
+$10.4M
4
INSM icon
Insmed
INSM
+$9.12M
5
SLDB icon
Solid Biosciences
SLDB
+$7.32M

Top Sells

Rank Stock Value
1
FWDI
Forward Industries Inc
FWDI
+$10.4M
2
FIGR
Figure Technology Solutions
FIGR
+$7.27M
3
NTSK
Netskope Inc
NTSK
+$6.82M
4
BBIO icon
BridgeBio Pharma
BBIO
+$6.56M
5
CRBG icon
Corebridge Financial
CRBG
+$6.41M

Sector Composition

Rank Sector Weight
1 Healthcare 63.26%
2 Industrials 15.21%
3 Financials 10.28%
4 Technology 5.52%
5 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GPCR icon
1
Structure Therapeutics
GPCR
$3.37B
$15.6M 8.82%
225,000
+25,000
+13% +$1.02M
MDLN
2
Medline Inc
MDLN
$33.9B
$12.6M 7.1%
+300,000
New +$12.7M
SOFI icon
3
SoFi Technologies
SOFI
$19.6B
$10.5M 5.9%
+400,000
New +$11.1M
ULS icon
4
UL Solutions
ULS
$18.6B
$10.3M 5.78%
+130,000
New +$10.4M
INSM icon
5
Insmed
INSM
$22.4B
$8.7M 4.9%
+50,000
New +$9.12M
TERN
6
DELISTED
Terns Pharmaceuticals
TERN
$7.97M 4.49%
+197,313
New +$4.56M
KYMR icon
7
Kymera Therapeutics
KYMR
$8.66B
$7.78M 4.38%
+100,000
New +$6.75M
MIAX
8
Miami International Holdings
MIAX
$4.49B
$7.77M 4.38%
175,000
+25,000
+17% +$1.11M
BBIO icon
9
BridgeBio Pharma
BBIO
$16.4B
$7.65M 4.31%
100,000
-100,000
-50% -$6.56M
SLDB icon
10
Solid Biosciences
SLDB
$792M
$7.61M 4.29%
+1,349,771
New +$7.32M
LGN
11
Legence Corp
LGN
$4.08B
$5.94M 3.35%
137,940
-12,060
-8% -$477K
IMNM icon
12
Immunome
IMNM
$2.62B
$5.9M 3.33%
+274,861
New +$4.82M
ITT icon
13
ITT
ITT
$17.1B
$5.56M 3.14%
+32,067
New +$5.75M
CMPX icon
14
Compass Therapeutics
CMPX
$349M
$5.37M 3.03%
1,000,000
-250,000
-20% -$1.15M
CYTK icon
15
Cytokinetics
CYTK
$10.6B
$4.77M 2.69%
75,000
-25,000
-25% -$1.56M
WLTH
16
Wealthfront Corp
WLTH
$1.38B
$4.08M 2.3%
+300,000
New +$3.98M
NKTR icon
17
Nektar Therapeutics
NKTR
$2.39B
$3.98M 2.24%
+94,134
New +$5.27M
SOMN
18
The Southern Company 2025 Series A Corp Units
SOMN
$3.82M 2.15%
+75,877
New +$3.76M
ADT icon
19
ADT
ADT
$5.43B
$3.23M 1.82%
400,000
-50,000
-11% -$416K
EVMN
20
Evommune Inc
EVMN
$398M
$3.14M 1.77%
+183,239
New +$3.44M
GOSS icon
21
Gossamer Bio
GOSS
$101M
$3.1M 1.75%
+1,000,000
New +$2.85M
NOVTU
22
Novanta Inc Units
NOVTU
$661M
$3.08M 1.73%
+55,962
New +$2.95M
LMRI
23
Lumexa Imaging Holdings
LMRI
$990M
$2.77M 1.56%
+150,000
New +$2.71M
ENGN icon
24
enGene Therapeutics
ENGN
$120M
$2.66M 1.5%
+295,000
New +$2.36M
AMBQ
25
Ambiq Micro
AMBQ
$1.38B
$2.43M 1.37%
85,089
-114,911
-57% -$3.29M
1
2 3 4

Similar funds

EFIC
Eliot Finkel Investment Counsel Beverly Hills, California $184M AUM 33.43% 1-Year Est. Return
SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
AAM
Ameraudi Asset Management New York $184M AUM 15.4% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
KWM
KMT Wealth Management El Segundo, California $184M AUM 17.2% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

Monashee Investment Management's Q4 2025 Portfolio in Review

As of Q4 2025, Monashee Investment Management held 88 positions worth $177M, down 12% from $201M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Monashee Investment Management withdrew a net $42.9M in Q4 2025, closing 48 positions and reducing 8 holdings. Its most notable exit was Forward Industries Inc, an estimated $10.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 63% of assets, up from 22% a quarter earlier, followed by Industrials and Financials.

Against the trend, Monashee Investment Management opened a new position in Medline Inc worth $12.6M.

  • Monashee Investment Management's largest Q4 2025 buy was Medline Inc: 300,000 shares worth $12.6M.
  • Monashee Investment Management added most to Miami International Holdings in Q4 2025, an estimated $1.11M increase.
  • Monashee Investment Management's biggest Q4 2025 reduction was BridgeBio Pharma, cutting an estimated $6.56M.
  • Monashee Investment Management fully exited Forward Industries Inc in Q4 2025, selling an estimated $10.4M.
  • Monashee Investment Management's ten largest holdings make up 54% of its $177M portfolio in Q4 2025.
  • Monashee Investment Management opened 28 new positions and closed 48 in Q4 2025.
  • Monashee Investment Management's portfolio value fell 12% quarter-over-quarter to $177M.

Based on Monashee Investment Management's 13F filing for Q4 2025, filed 12 Feb 2026.